Recent comprehensive studies have highlighted that pathogenic variants (PVs) across eight distinct genes, such as ATM, BRCA1, BRCA2, CHEK2, PALB2 (FANCN), RAD51C, and RAD51D, exhibit a substantial correlation with breast cancer risk (Table 1). This evidence concerns the gene BRCA2 and breast carcinoma.